Related Experiment Video

Updated: Jun 28, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Recurrence and spontaneous remission of membranous nephropathy after renal transplantation

R Liebl1, B K Krämer

  • 1KfH-Nierenzentrum and internistisch-nephrologische Gemeinschafts-praxis, Günzstrasse 4, Regensburg, Germany. robert.liebl@kfh-dialyse.de

Clinical Nephrology
|November 13, 2008
PubMed

Insights

Membranous nephropathy, a common cause of nephrotic syndrome, may spontaneously remit after kidney transplant. This suggests observed remissions might not always be due to treatment.

Area of Science:

  • Nephrology
  • Immunology

Background:

  • Membranous nephropathy is the leading cause of nephrotic syndrome in adults.
  • It affects 5% of patients, leading to renal failure and dialysis.
  • Recurrent membranous nephropathy occurs in 10-30% of kidney transplant recipients.

Observation:

  • This case report details a patient with recurrent membranous nephropathy post-kidney transplantation.
  • The patient experienced a likely spontaneous clinical remission.

Findings:

  • Spontaneous remission of membranous nephropathy can occur even after renal transplantation.
  • Observed remissions following various treatments may be spontaneous rather than therapy-induced.

Implications:

  • This finding challenges the direct attribution of remission solely to therapeutic interventions.
  • It highlights the potential for natural resolution in recurrent membranous nephropathy.
  • Further research is needed to differentiate spontaneous from treatment-related remissions.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...